首页> 外国专利> SELECTIVE CD8-POSITIVE T CELL-INDUCING VACCINE ANTIGEN

SELECTIVE CD8-POSITIVE T CELL-INDUCING VACCINE ANTIGEN

机译:选择性CD8阳性T细胞疫苗抗原

摘要

A polypeptide for selectively inducing a target antigen-specific CD8-positive T cell response is provided. Induction of vaccine-derived human immunodeficiency virus (HIV)-specific CD4-positive T cell response can promote HIV infection, so it would be useful to be able to obtain an HIV vaccine antigen that selectively induces an HIV-specific CD8-positive T cell response. In this invention, the amino acid sequence of a target antigen protein is divided into amino sequences of 8-12 residues, and a polypeptide antigen is designed in which these are linked in a sequence different from that of the original amino acid sequence. As a result of experiments on monkeys involving inoculation of vaccines using viral vectors and DNA expressing this antigen, it was shown that it is possible to efficiently and selectively induce an antigen-specific CD8-positive T cell response. This antigen is thought to be useful as a CD8-positive T cell-inducing vaccine antigen with extremely high selectivity.
机译:提供了一种用于选择性诱导靶抗原特异性CD8阳性T细胞应答的多肽。诱导疫苗衍生的人免疫缺陷病毒(HIV)特异性CD4阳性T细胞反应可促进HIV感染,因此能够获得选择性诱导HIV特异性CD8阳性T细胞的HIV疫苗抗原将是有用的。响应。在本发明中,将靶抗原蛋白的氨基酸序列分为8至12个残基的氨基序列,并设计了多肽抗原,其中它们以不同于原始氨基酸序列的序列连接。作为使用病毒载体和表达该抗原的DNA对猴子进行疫苗接种实验的结果,表明可以有效和选择性地诱导抗原特异性CD8阳性T细胞应答。该抗原被认为以极高的选择性用作诱导CD8阳性T细胞的疫苗抗原。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号